This site is intended for healthcare professionals
Transplantation Channel
Transplantation Learning Zone
Declaration of sponsorship Novartis Pharma AG

EACCME® accredited module

Declaration of sponsorship Novartis Pharma AG
Read time: 50 mins
Last updated:10th May 2021
Published:10th May 2021

Launch our CME accredited eLearning module to find out where we are with calcineurin inhibitor-free immunosuppressive regimens for renal transplantation and discover how new predictive tools can help achieve long-term kidney graft survival. This webinar-based module is chaired by Professor Julio Pascual and includes expert input from Professor Stefan Berger, Professor Helio Tedesco Silva and Dr Olivier Aubert.

Achieving long-term outcomes in renal transplantation

Receive 1 European CME credit (ECMEC®) when you complete our webinar-based eLearning module. On completion of this course you will understand the limitations of CNI therapy for renal transplant recipients and the emerging strategies to overcome the issue of CNI toxicity.

Enrol

Closing survey Your feedback and certificate access 5 mins
Introduction Introduction to the CME course 5 mins
Section 1 Welcome and Introduction 1 min
Section 2 Where are we now? Edging towards a CNI-free immunosuppressant regime in renal transplantation 14 mins
Section 3 Current immunosuppressive strategies for reducing CNI use in renal transplantation 8 mins
Section 4 Can predictive tools help to achieve long-term kidney graft survival? 15 mins
Quiz Assessment questions 12 mins

Course overview

How much do you know about evolving immunosuppressant approaches for renal transplant recipients and are you familiar with newly developed tools for the prediction of allograft loss in these patients?

Put your knowledge to the test with our interactive CME accredited module, which includes information on calcineurin inhibitor-sparing immunosuppressant strategies and introduces iBox, the first universal algorithm for the prediction of kidney transplant loss.

Following a brief introduction to the module, you will be shown video footage from our webinar, ‘Achieving long-term outcomes in renal transplantation - what’s on the horizon?’, which includes contributions from four expert faculty. You will then be asked a series of assessment questions based on the video you have just watched.

System Requirements

Faculty

Professor Julio Pascual
Professor Pascual is the Chief at the Nephrology Department and Kidney Transplantation at Hospital del Mar in Barcelona, Spain. He is also the Chief of the Kidney Diseases Research Group at the Biomedical Research Park in Barcelona. Professor Pascual completed a fellowship in Research and Transplantation at the University of Wisconsin, USA, in 2006-2007.

Professor Stefan Berger
Professor Berger is a nephrologist and director of the kidney and pancreas transplant program at UMCG. He is a member of the board of the Groningen Transplant Centre and chair of the Dutch Kidney Transplantation Advisory Committee.

Professor Helio Tedesco Silva
Helio Tedesco Silva is a Professor at the Nephrology Division of Hospital Do Rim at the Federal University of São Paulo. Helio obtained his medical degree in 1984 at the Paulista School of Medicine, Federal University of São Paulo and pursued postgraduate studies to obtain his PhD in Nephrology in 1994.

Dr Olivier Aubert
Dr Olivier Aubert in a nephrologist at the Department of Nephrology and Kidney Transplantation at Necker Hospital in Paris, France. He joined the Paris Transplant Group in 2012. He defended his M.D in 2014 and his PhD in biostatistics and epidemiology in 2017.

Further information

Evaluation questions will be asked at the end of the module. You must achieve a score of 70% or above to pass the course and receive your CME certificate.

At the end of the course, you will also be asked to complete a short survey, giving you the chance to provide feedback on your experience of the module.

On completion of this course, participants will understand:

  • the limitations of CNI therapy for renal transplant recipients
  • emerging strategies to overcome the issue of CNI toxicity
  • the potential benefits of co-stimulation blockade in renal transplant recipients
  • the development and clinical importance of the iBox algorithm

Achieving long-term outcomes in renal transplantation

Receive 1 European CME credit (ECMEC®) when you complete our webinar-based eLearning module. On completion of this course you will understand the limitations of CNI therapy for renal transplant recipients and the emerging strategies to overcome the issue of CNI toxicity.

Enrol

Welcome: